Does post-COVID reactive arthritis exist? Experience of a tertiary care centre with a review of the literature Atanu Pal, Rashmi Roongta, Sumantro Mondal, Debanjali Sinha, Pradyot Sinhamahapatra, Alakendu Ghosh, Arghya Chattopadhyay

One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registry Clementina López-Medina, Lucía Otero-Varela, Fernando Sánchez-Alonso, Vega Jovaní, Lorena Expósito-Pérez, Sheila Melchor-Díaz, Yanira Pérez-Vera, Paula Pretel-Ruiz, Javier Manero, Antonio Mera-Varela, Lourdes Mateo, Dolores Ruiz-Montesino, José Andrés Lorenzo-Martín, Teresa Pedraz-Penalva, Isabel Castrejón

Costs of the standard rheumatology care in active rheumatoid arthritis patients seen in a tertiary care center in Mexico City Blanca Hernández-Cruz, Rafael Ariza-Ariza, Mario H. Cardiel-Ríos